期刊文献+

心肌生长刺激因子的分离、纯化及生化鉴定(英文) 被引量:1

Purification and bioactivity study of Myocardium Growth Stimulating Factor
下载PDF
导出
摘要 目的 从人胚胎心室肌细胞中提出了一种在体外可刺激Wistar小鼠原代心肌细胞DNA合成并具有生物活性的纯化物质 ,称之为心肌生长刺激因子 (MyocardiumGrowthStimulatingFactor,MGSF)。 方法 采用硫酸铵分级离法、阴离子纤维素交换层析、高压液相色谱洗脱、SDS -PAGE、毛细管电泳、高压液相色谱分离及生化鉴定。结果 该物质分子量为 3.7KDa ,含有 17种氨基酸 ,同最新的蛋白质氨基酸序列文库扫描进行同源性分析 ,并确定此序列可能为一种新的氨基酸序列 ;并对其进行了生化鉴定 ,其临床意义正在进一步研究这中。结论 该研究结果初步表明 ,MGSF可能为急性缺血性心脏病提供有效的药物治疗开辟了一条新的思路。 Objective:To separate and purify a protein-Myocardium Growth Factor(MGSF) that has bioactivity in vitro from ventricle muscle of human embryo.Methods:DEAE-52 cellulose exchange chromatography, SDS-PAGE and so on were used to separate and purify MGSF.And the purity, amino acid proximate analysis, N-terminal amino acid sequence of this protein and its bioactivity were studied by SDS-PAGE, capillary zone electrophoresis.Results:MGSF's molecular weight was about 3.7 Kda, it contained 17 kinds of amino acid, the homogenous material had been not found by scanning of protein library.Conclusions:MGSF may be a new drug to treat acute ischemic heart disease. And its clinical use should be further studied.
出处 《中国现代医学杂志》 CAS CSCD 2003年第22期15-18,共4页 China Journal of Modern Medicine
基金 SupportedbytheNaturalScienceFunalofHunanProvince .
关键词 心肌生长刺激因子 分离 纯化 生化鉴定 心室肌细胞 胚胎 急性缺血性心脏病 氨基酸序列 Myocardium Growth Stimulating Factor Purification Bioactivity analysis
  • 相关文献

参考文献6

  • 1[1]Long CS,Kariya K,Karns L,et al.Trophic factor for Cardiac myocytes [J].J Hypertens Suppl,1990,8(7):219-224.
  • 2[2]Nagano M,Ohkubo T,Ariono T,et al.Growth factor for cardiac hypertroph[J].Mol Cell Biochem,1993,119(1-2):17-22.
  • 3[3]Long CS,Kariya K,Karus L,et al.Sympathetic modulation of the cardiac myocyte phenotype:Studies with a cell culture model of myocardial hypertrophy[J].Basic Res Cardiol,1992,2:19-31.
  • 4[4]Kardami B,Stimulation and inhibition of cardiac myocyte proliferation in vitro[J].Mol Cell Biochem,1990,92(2):129-135.
  • 5[5]Swedberg K,Held P,Kje R,et al.Effects aministration of enalapril on mortality in patients with acute myocardial infarction.Result of cooperative .New Scandinavian Enalapreil survival study Ⅱ (consensus Ⅱ)[J].New Eng J Mes,1992,327:678.
  • 6刘同奎,孔晓光,朴晶燕,王桂照.老年急性心肌梗塞的诊疗进展[J].中国现代医学杂志,2001,11(1):24-26. 被引量:13

二级参考文献19

  • 1刘同奎,修萍,董玉珠,马立群.急性心肌梗塞溶栓治疗的现状[J].中国危重病急救医学,1996,8(6):374-376. 被引量:4
  • 2[1]Krumholz HM,Chen J,Wang Y,et al.Comparing AMI mortality among hospitals in patients 65 years of age and older:evaluting methods of risk adjustments.Circulation,1999:99(23):2986~2992
  • 3[3]Miller TR,Grossman SJ,Schectman KB,et al.Left ventricular diastolic filling and its association with age.Am J Cardiol,1986;58:531~535
  • 4[4]Borzak S,Cannon CP,Kraft PL,et al.Effects of prior aspirin and anti-ischemic therapy on outcome of patients with unstable angina TiMi 7 in Vestigators Thrombin inhibition in Myocardial zschemia.Am J Cardiol,1998 Mar 15;81(6):678~681
  • 5[5]White HD,Barbash GI,Califf RM,et al.Age and outcome with contemporary thrombolytic therapy:results from the GUSTO-T trial.Circulation,1996;94:1826~1833
  • 6[6]Krumholz HM,Murilo JE,Chen J,et al.Thrombolytic therapy for eligile elderly patients with acute myocardial infarction.JAMA,1995;273:1509~15014
  • 7[7]Perez-Castellano N,Garcia E,Serrano JA,et al.Efficacy of invasive strategy for the managemetn of acute myocardial infarction complicated by cardiogenic shock.Am J Cardiol,1999;83(77):989~993
  • 8[8]Lindblomm EJ,Stevermer JJ.Cardiac tropnin I as a marker for AMI (letter).Am Heart J,1999;138(4):798~800
  • 9[9]Berger AK,Schulman KA,Gersh BJ,et al.Primary coronary angioplasty vs thrombolysis for the management of acute myocardial infarction in elderly patient.JAMA,1999;28:28(4):341~348
  • 10[10]Antoniucci D,Valent R,Santoro GM,et al.Systematic primary angioplasty in octogenarian and older patient.Am Heart J,1999;138(4):670~674

共引文献12

同被引文献3

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部